Invasive Aspergillosis Completed Phase 2 Trials for Isavuconazonium (DB06636)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0031838 (Invasive Aspergillosis) | Completed | 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT03816176 | A Study to Evaluate Isavuconazonium Sulfate for the Treatment of Invasive Aspergillosis (IA) or Invasive Mucormycosis (IM) in Pediatric Participants | Treatment |